Drug
Milsaperidone
Milsaperidone: highest development phase Phase 3, developed by Vanda Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Vanda Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Milsaperidone NCT06830044 | Phase 3 | Major Depressive Disorder (MDD) |
Latest
No recent events.
Follow Milsaperidone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.